Physician profile
Amit Rastogi
NPI 1447356415
$62,882.66
in general payments reported to CMS, 2019-2025
17 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $9,809 · 2021: $293 · 2022: $2,214 · 2023: $8,571 · 2024: $14K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Consulting Fee: $1,873 · Food and Beverage: $1,773 · Travel and Lodging: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,422.50 |
| Consulting Fee | $1,872.50 |
| Food and Beverage | $1,772.86 |
| Travel and Lodging | $1,207.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $37,482.14 | 2020-2025 | General - Therapies, Resolution 360 Clip, Axios |
| Wilson Cook Medical Incorporated | $12,145.84 | 2019-2020 | |
| Olympus Corporation | $5,842.50 | 2020-2023 | |
| Chugai Pharmaceutical Co., LTD. | $2,846.22 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,517.76 | 2022-2023 | Xifaxan |
| Cook Medical LLC | $1,305.80 | 2019-2025 | Echotip Insight, Hemospray, Echotip |
| Olympus Medical Systems Corporation | $335.00 | 2025 | |
| Erbe USA INC | $140.17 | 2023 | Erbe Vio3 |
| Intuitive Surgical, INC. | $70.07 | 2021 | |
| Olympus America INC. | $62.38 | 2024 | Gastrointestinal Videoscope, Evis Exera II Ultrasound Gastrovideoscope, Evis Exera III Colonovideoscope |
| Takeda Pharmaceuticals U.S.A., INC. | $47.62 | 2021-2022 | |
| Olympus Corporation of The Americas | $29.00 | 2020 | |
| Janssen Biotech, INC. | $25.48 | 2021 | |
| Celgene Corporation | $13.37 | 2022 | |
| Allergan, INC. | $11.54 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micro-Tech Endoscopy USA, INC. | $7.77 | 2024 | Lockado |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Rastogi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.